Mutual Funds Holding Caplin Point Laboratories Limited

Healthcare8 fundsISIN INE475E01026

As of 31 July 2026, 8 Indian mutual funds hold Caplin Point Laboratories Limited (Healthcare), led by UTI - Healthcare Fund at 3.95% of its net assets, per the AMCs' SEBI-mandated monthly disclosures.

As of 31 July 2026, 8 Indian mutual fund schemes disclose a holding in Caplin Point Laboratories Limited (Healthcare). The table below lists every fund holding this stock along with its weight as a percentage of the fund's net assets (% to NAV), sorted from the highest conviction position downward.

Holding Analysis

Across the 8 funds holding Caplin Point Laboratories Limited, the average position size is 1.58% of net assets. The highest-conviction holder is UTI - Healthcare Fund (Thematic), at 3.95%. Equity funds account for 5 of the 8 holders, with the rest spread across 2 other categories. Over the last month, 3 funds initiated a new position and 1 fund exited.

Fund Activity Last Month

How funds changed their Caplin Point Laboratories Limited position between their two latest monthly disclosures. Weights are % to NAV; weight moves can also reflect price changes, not only buying or selling.

3 started a position1 exited

Funds Holding Caplin Point Laboratories Limited

#FundAMCCategory% to NAV
1UTI - Healthcare FundUTI Mutual FundThematic3.95%
2UTI Small Cap FundUTI Mutual FundEquity1.73%
3Quantum Small Cap FundQuantum Mutual FundEquity1.64%
4The Wealth Company Balanced Advt FundThe Wealth Company Mutual FundHybrid1.45%
5The Wealth Company Small Cap FundThe Wealth Company Mutual FundEquity1.28%
6UTI Large & Mid Cap FundUTI Mutual FundEquity1.18%
7UTI Aggressive Hybrid FundUTI Mutual FundHybrid0.96%
8Samco Small Cap FundSamco Mutual FundEquity0.42%

Want to interpret these weights? Read How to Read a Mutual Fund's Monthly Portfolio Disclosure, or look up terms like % to NAV and conviction in the glossary.

Source: SEBI-mandated monthly portfolio disclosures by Indian AMCs. Percentages are of each fund's net assets on its latest disclosure date. For information only, not investment advice.